Four-Cent Inhaler
Drugmakers are increasingly turning to inhalable versions of vaccines and drugs in order to avoid the hassle and danger of syringes. A new inhaler that costs only four cents could administer powdered drugs as effectively as traditional inhalers that cost 10 times as much. The technology, which uses no moving parts, could help poor countries stop relying on syringes, which cost pennies apiece but require trained staff and carry an infection risk. To make their inhaler cheaper, engineers at Cambridge Consultants of Cambridge, England, and Boston focused on its internal shape. When a user inhales, a kind of miniature tornado forms inside the device, lifting a powdered drug into the air. The company is in talks with pharmaceutical firms to test the device with a powdered flu vaccine, among other drugs. Though an inhaler is a fraction of the price of a vaccine dose (currently $3 to $7), the savings could make a difference. “Everyone in the field dreams of a future with these kinds of simple, low-cost vaccine delivery systems,” says Donald Francis, cofounder of Global Solutions for Infectious Diseases, a nonprofit vaccine developer. “Moving to a needle-free model is a goal most of us share.”

Keep Reading
Most Popular
The inside story of how ChatGPT was built from the people who made it
Exclusive conversations that take us behind the scenes of a cultural phenomenon.
How Rust went from a side project to the world’s most-loved programming language
For decades, coders wrote critical systems in C and C++. Now they turn to Rust.
Design thinking was supposed to fix the world. Where did it go wrong?
An approach that promised to democratize design may have done the opposite.
Sam Altman invested $180 million into a company trying to delay death
Can anti-aging breakthroughs add 10 healthy years to the human life span? The CEO of OpenAI is paying to find out.
Stay connected
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.